Monday, June 17, 2013

CEO of MELA Sciences, Inc. (MELA) Resigns, Robert Coradini to Fill in Temporarily

MELA Sciences, a medical device company and developer of MelaFind(R), announced today that Joseph Gulfo has resigned as Chairman, President, Chief Executive Officer, and member of the Board of Directors. Member of the Board of Directors since December 2011, Robert Coradini will serve as interim CEO while the board hunts for a new Chief Executive Officer. Coradini has over 20 years of experience in the health care industry both leading and managing businesses for Johnson & Johnson and GE Medical Systems, now known as GE Healthcare.

While at Johnson & Johnson, Coradini held a variety of senior leadership positions. Acting as President of various subsidiaries of J&J, including Lifescan, Cordis Endovascular, and Cardiovations (Ethicon), Coradini was the head of business development of the Medical Devices & Diagnostics Group. Most recently he sat as President of New Ventures for the Johnson & Johnson Consumer Group of Companies, overseeing the OrthoNeutrogena division, now known as Ortho Dermatologics after being acquired by Valeant International.

“We are thankful for Joseph’s leadership over the past nine years as the company has undergone a successful transformation from product development, to FDA Approval, to early commercial launch of MelaFind(R) in the US and Germany,” stated Coradini. “The Board and I believe in the technology as a major advance for dermatologists in their fight against Melanoma. It is our intent to work closely with these physicians to succeed. We wish Joseph the best in the next phase of his career.”

Resulting from these recent changes, David Stone who has served as Lead Independent Director will assume the role of Chairman of the board. In addition he will lead the search for Gulfo’s replacement.

MELA Sciences is currently focused on the commercialization of FDA-approved MelaFind(R). To learn more, visit www.melasciences.com

CEO of MELA Sciences, Inc. (MELA) Resigns, Robert Coradini to Fill in Temporarily

MELA Sciences, a medical device company and developer of MelaFind(R), announced today that Joseph Gulfo has resigned as Chairman, President, Chief Executive Officer, and member of the Board of Directors. Member of the Board of Directors since December 2011, Robert Coradini will serve as interim CEO while the board hunts for a new Chief Executive Officer. Coradini has over 20 years of experience in the health care industry both leading and managing businesses for Johnson & Johnson and GE Medical Systems, now known as GE Healthcare.

While at Johnson & Johnson, Coradini held a variety of senior leadership positions. Acting as President of various subsidiaries of J&J, including Lifescan, Cordis Endovascular, and Cardiovations (Ethicon), Coradini was the head of business development of the Medical Devices & Diagnostics Group. Most recently he sat as President of New Ventures for the Johnson & Johnson Consumer Group of Companies, overseeing the OrthoNeutrogena division, now known as Ortho Dermatologics after being acquired by Valeant International.

“We are thankful for Joseph’s leadership over the past nine years as the company has undergone a successful transformation from product development, to FDA Approval, to early commercial launch of MelaFind(R) in the US and Germany,” stated Coradini. “The Board and I believe in the technology as a major advance for dermatologists in their fight against Melanoma. It is our intent to work closely with these physicians to succeed. We wish Joseph the best in the next phase of his career.”

Resulting from these recent changes, David Stone who has served as Lead Independent Director will assume the role of Chairman of the board. In addition he will lead the search for Gulfo’s replacement.

MELA Sciences is currently focused on the commercialization of FDA-approved MelaFind(R). To learn more, visit www.melasciences.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: